BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27357718)

  • 41. Aerobic capacity and its correlates in patients with ankylosing spondylitis.
    Hsieh LF; Wei JC; Lee HY; Chuang CC; Jiang JS; Chang KC
    Int J Rheum Dis; 2016 May; 19(5):490-9. PubMed ID: 24754841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis.
    Hamdi W; Chelli Bouaziz M; Zouch I; Ghannouchi MM; Haouel M; Ladeb MF; Kchir MM
    J Rheumatol; 2012 Feb; 39(2):322-6. PubMed ID: 22247364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria.
    Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Kalstad S; Kvien TK
    Rheumatology (Oxford); 2012 Aug; 51(8):1479-83. PubMed ID: 22499062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.
    Cowling P; Ebringer R; Cawdell D; Ishii M; Ebringer A
    Ann Rheum Dis; 1980 Feb; 39(1):45-9. PubMed ID: 7377858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of IL-2 and IL-11 and its significance in patients with ankylosing spondylitis.
    Liu F; Wang F; Wang CC; Li N; Li SF
    Asian Pac J Trop Med; 2013 Jan; 6(1):76-8. PubMed ID: 23317891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between clinical and MRI disease activity scores in axial spondyloarthritis.
    MacKay JW; Aboelmagd S; Gaffney JK
    Clin Rheumatol; 2015 Sep; 34(9):1633-8. PubMed ID: 25894437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.
    Li Q; Li L; Bi L; Xiao C; Lin Z; Cao S; Liao Z; Gu J
    Trials; 2016 Jul; 17(1):337. PubMed ID: 27449221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mannose-Binding Lectin Deficiency in Brazilian Patients with Spondyloarthritis.
    Skare TL; Nisihara R; Cieslinski JZ; Zeni JO; Rasera HN; Messias-Reason I; Utiyama SR
    Immunol Invest; 2017 Feb; 46(2):183-189. PubMed ID: 27911110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome.
    Nashel DJ; Petrone DL; Ulmer CC; Sliwinski AJ
    J Rheumatol; 1986 Apr; 13(2):364-7. PubMed ID: 3723498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.
    Rahman P; Choquette D; Bensen WG; Khraishi M; Chow A; Zummer M; Shaikh S; Sheriff M; Dixit S; Sholter D; Psaradellis E; Sampalis JS; Letourneau V; Lehman AJ; Nantel F; Rampakakis E; Otawa S; Shawi M
    BMJ Open; 2016 Apr; 6(4):e009661. PubMed ID: 27048632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China.
    Xu M; Lin Z; Deng X; Li L; Wei Y; Liao Z; Li Q; Wei Q; Hu Z; Zhang Y; Lin Q; Huang J; Li T; Pan Y; Wu Y; Jin O; Yu B; Gu J
    Rheumatology (Oxford); 2011 Aug; 50(8):1466-72. PubMed ID: 21441550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis.
    Yildirim K; Erdal A; Karatay S; Melikoğlu MA; Uğur M; Senel K
    South Med J; 2004 Apr; 97(4):350-3. PubMed ID: 15108827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis.
    Nas K; Yildirim K; Cevik R; Karatay S; Erdal A; Baysal O; Altay Z; Kamanli A; Ersoy Y; Kaya A; Durmus B; Ardicoglu O; Tekeoglu I; Ugur M; Sarac AJ; Senel K; Gur A; Ozgocmen S
    Int J Rheum Dis; 2010 Aug; 13(3):240-5. PubMed ID: 20704621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum galectin-3 concentrations in patients with ankylosing spondylitis.
    Cao MY; Wang J; Gao XL; Hu YB
    J Clin Lab Anal; 2019 Jul; 33(6):e22914. PubMed ID: 31106498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sacroiliitis in patients with ankylosing spondylitis: association of MR findings with disease activity.
    Jee WH; McCauley TR; Lee SH; Kim SH; Im SA; Ha KY
    Magn Reson Imaging; 2004 Feb; 22(2):245-50. PubMed ID: 15010117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up.
    Kneepkens EL; Krieckaert CL; van der Kleij D; Nurmohamed MT; van der Horst-Bruinsma IE; Rispens T; Wolbink GJ
    Ann Rheum Dis; 2015 Oct; 74(10):1825-9. PubMed ID: 24812290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease.
    Gupta L; Bhattacharya S; Agarwal V; Aggarwal A
    Clin Rheumatol; 2016 Dec; 35(12):3075-3079. PubMed ID: 27738838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Association of Fecal Microbiota in Ankylosing Spondylitis Cases with C-Reactive Protein and Erythrocyte Sedimentation Rate.
    Liu G; Hao Y; Yang Q; Deng S
    Mediators Inflamm; 2020; 2020():8884324. PubMed ID: 33204218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.
    Poddubnyy D; Protopopov M; Haibel H; Braun J; Rudwaleit M; Sieper J
    Ann Rheum Dis; 2016 Dec; 75(12):2114-2118. PubMed ID: 27125522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
    de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
    Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.